Announcement on Obtainment of the "Drug Registration Certificate" for Loxoprofen Sodium Cataplasm

About this update from Hunan Fangsheng Pharmaceutical Co., Ltd. Class A

Announcement on Obtainment of the "Drug Registration Certificate" for Loxoprofen Sodium Cataplasm The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hunan Fangsheng Pharmaceutical Co., Ltd. Class A